Liquidia (LQDA) Competitors $13.97 +0.46 (+3.40%) As of 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock LQDA vs. INSP, BLCO, SLNO, IRTC, TMDX, PRCT, NVST, LMAT, LIVN, and ENOVShould you be buying Liquidia stock or one of its competitors? The main competitors of Liquidia include Inspire Medical Systems (INSP), Bausch + Lomb (BLCO), Soleno Therapeutics (SLNO), iRhythm Technologies (IRTC), TransMedics Group (TMDX), PROCEPT BioRobotics (PRCT), Envista (NVST), LeMaitre Vascular (LMAT), LivaNova (LIVN), and Enovis (ENOV). These companies are all part of the "medical equipment" industry. Liquidia vs. Inspire Medical Systems Bausch + Lomb Soleno Therapeutics iRhythm Technologies TransMedics Group PROCEPT BioRobotics Envista LeMaitre Vascular LivaNova Enovis Inspire Medical Systems (NYSE:INSP) and Liquidia (NASDAQ:LQDA) are both medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, dividends, media sentiment, profitability, analyst recommendations, community ranking, valuation, earnings and risk. Which has higher earnings and valuation, INSP or LQDA? Inspire Medical Systems has higher revenue and earnings than Liquidia. Liquidia is trading at a lower price-to-earnings ratio than Inspire Medical Systems, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioInspire Medical Systems$802.80M5.87$53.51M$1.7391.58Liquidia$14.00M85.14-$78.50M-$1.67-8.37 Does the MarketBeat Community favor INSP or LQDA? Liquidia received 12 more outperform votes than Inspire Medical Systems when rated by MarketBeat users. Likewise, 68.77% of users gave Liquidia an outperform vote while only 61.71% of users gave Inspire Medical Systems an outperform vote. CompanyUnderperformOutperformInspire Medical SystemsOutperform Votes19561.71% Underperform Votes12138.29% LiquidiaOutperform Votes20768.77% Underperform Votes9431.23% Which has more risk and volatility, INSP or LQDA? Inspire Medical Systems has a beta of 1.39, indicating that its share price is 39% more volatile than the S&P 500. Comparatively, Liquidia has a beta of 0.23, indicating that its share price is 77% less volatile than the S&P 500. Do analysts recommend INSP or LQDA? Inspire Medical Systems currently has a consensus target price of $218.90, suggesting a potential upside of 38.17%. Liquidia has a consensus target price of $26.63, suggesting a potential upside of 90.59%. Given Liquidia's stronger consensus rating and higher possible upside, analysts plainly believe Liquidia is more favorable than Inspire Medical Systems.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Inspire Medical Systems 0 Sell rating(s) 3 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 2.70Liquidia 0 Sell rating(s) 1 Hold rating(s) 6 Buy rating(s) 2 Strong Buy rating(s) 3.11 Is INSP or LQDA more profitable? Inspire Medical Systems has a net margin of 6.67% compared to Liquidia's net margin of -765.38%. Inspire Medical Systems' return on equity of 8.19% beat Liquidia's return on equity.Company Net Margins Return on Equity Return on Assets Inspire Medical Systems6.67% 8.19% 7.09% Liquidia -765.38%-163.21%-67.14% Does the media favor INSP or LQDA? In the previous week, Inspire Medical Systems had 2 more articles in the media than Liquidia. MarketBeat recorded 14 mentions for Inspire Medical Systems and 12 mentions for Liquidia. Inspire Medical Systems' average media sentiment score of 1.45 beat Liquidia's score of 1.09 indicating that Inspire Medical Systems is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Inspire Medical Systems 12 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Liquidia 7 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Do institutionals & insiders believe in INSP or LQDA? 94.9% of Inspire Medical Systems shares are held by institutional investors. Comparatively, 64.5% of Liquidia shares are held by institutional investors. 4.1% of Inspire Medical Systems shares are held by insiders. Comparatively, 30.1% of Liquidia shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term. SummaryInspire Medical Systems beats Liquidia on 12 of the 19 factors compared between the two stocks. Get Liquidia News Delivered to You Automatically Sign up to receive the latest news and ratings for LQDA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart LQDA vs. The Competition Export to ExcelMetricLiquidiaPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.19B$6.90B$5.57B$7.82BDividend YieldN/A3.06%5.11%4.22%P/E Ratio-8.577.4522.4218.48Price / Sales85.14242.72394.10103.91Price / CashN/A65.8538.1834.62Price / Book19.146.516.774.25Net Income-$78.50M$143.21M$3.22B$248.23M7 Day Performance3.10%3.97%3.26%3.29%1 Month Performance-7.42%0.37%0.02%2.42%1 Year Performance8.72%2.60%18.01%5.54% Liquidia Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)LQDALiquidia2.8422 of 5 stars$13.97+3.4%$26.63+90.6%+8.3%$1.19B$14.00M-8.5750Positive NewsINSPInspire Medical Systems4.8522 of 5 stars$144.74-3.6%$218.90+51.2%-34.5%$4.31B$802.80M83.67760Upcoming EarningsNews CoverageGap UpBLCOBausch + Lomb3.8275 of 5 stars$12.05-0.1%$18.82+56.2%-9.3%$4.26B$4.79B-13.2412,500Earnings ReportNews CoverageGap DownSLNOSoleno Therapeutics4.6455 of 5 stars$68.93-1.5%$99.63+44.5%+65.3%$3.16BN/A-20.7630Positive NewsGap DownIRTCiRhythm Technologies0.9766 of 5 stars$98.63-2.3%$119.73+21.4%-1.8%$3.10B$591.84M-27.101,790Upcoming EarningsNews CoveragePositive NewsTMDXTransMedics Group3.0331 of 5 stars$87.72-0.6%$122.70+39.9%-5.0%$2.97B$441.54M93.32210Analyst ForecastGap DownPRCTPROCEPT BioRobotics2.7173 of 5 stars$53.43+0.8%$91.43+71.1%+8.2%$2.93B$224.50M-27.40430Earnings ReportAnalyst RevisionHigh Trading VolumeNVSTEnvista4.4279 of 5 stars$14.88-2.0%$19.96+34.2%-21.4%$2.56B$2.51B-2.2912,700Upcoming EarningsAnalyst ForecastPositive NewsLMATLeMaitre Vascular2.166 of 5 stars$84.72-1.8%$95.25+12.4%+39.8%$1.91B$219.86M46.30490Upcoming EarningsPositive NewsLIVNLivaNova3.7973 of 5 stars$34.61-2.7%$61.17+76.7%-33.0%$1.88B$1.25B82.402,900Upcoming EarningsNews CoveragePositive NewsENOVEnovis2.7286 of 5 stars$32.25+0.9%$58.50+81.4%-37.7%$1.84B$2.11B-14.736,800News CoveragePositive News Related Companies and Tools Related Companies Inspire Medical Systems Competitors Bausch + Lomb Competitors Soleno Therapeutics Competitors iRhythm Technologies Competitors TransMedics Group Competitors PROCEPT BioRobotics Competitors Envista Competitors LeMaitre Vascular Competitors LivaNova Competitors Enovis Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:LQDA) was last updated on 4/30/2025 by MarketBeat.com Staff From Our Partners"I'm risking my reputation on this"I've discovered something so significant about the 2025 crypto market that I had to put everything else aside ...Crypto 101 Media | SponsoredTop performing AI play of the decade…? (The answer will shock you)You’ve seen the headlines about Nvidia. Now Tim Sykes is sounding the alarm — because what CEO Jensen Huang is...Timothy Sykes | SponsoredMusk’s AI Masterplan – Our #1 AI Stock to Buy NowDid Elon Musk just set the stage for the next AI stock explosion? One 30-year Wall Street veteran thinks so...Behind the Markets | SponsoredM.A.G.A. is Finished – This Could be even BetterYou’ve no doubt heard Trump’s rally cry: Make America Great Again. But recently the President made a big ch...Paradigm Press | SponsoredChina’s next move could destroy U.S. techThe U.S. fired the first shot with 145% tariffs. Apple relies heavily on Chinese production. Tesla needs Ch...Investors Alley | SponsoredMassive new energy source found in UtahNEW THIS WEEK: Huge Energy Discovery In Utah The Department of Energy say it could power America for millio...Stansberry Research | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe July 23rd Crypto Trigger Could Mark the Beginning of Bitcoin’s Next Big Move Bitcoin’s early 2024 ETF r...Crypto Swap Profits | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Liquidia Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Liquidia With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy LQDA Stock Free LQDA Stock Alerts